MENA Programme Region vs Palestine: Percentage of surviving infants who received the third dose of hep
MENA Programme Region
83
in 2025
Palestine
99
in 2025
MENA Programme Region rank
2nd
Palestine rank
1st
Percentage of surviving infants who received the third dose of hep over time
- MENA Programme Region
- Palestine
How they compare
Palestine currently reports 99 against 83 in MENA Programme Region, a difference of 16.
That makes Palestine's figure about 1.2 times MENA Programme Region's.
Across all 31 years both countries report, Palestine has been ahead every year.
MENA Programme Region ranks 2nd and Palestine ranks 1st of 2 groups.
Palestine has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | MENA Programme Region | Palestine | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.2 | 92.8 | 44.6 | Palestine |
| 2000s | 75.3 | 95.8 | 20.5 | Palestine |
| 2010s | 89.1 | 98.9 | 9.8 | Palestine |
| 2020s | 83.33 | 96.83 | 13.5 | Palestine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of surviving infants who received the third dose of hep, MENA Programme Region or Palestine?
- Palestine, at 99 against 83 in MENA Programme Region as of 2025.
- What is the difference in percentage of surviving infants who received the third dose of hep between MENA Programme Region and Palestine?
- 16, with Palestine ahead.
- How many years of comparable data are there for MENA Programme Region and Palestine?
- 31 years are reported by both, from 1995 to 2025.
- How do MENA Programme Region and Palestine rank globally for percentage of surviving infants who received the third dose of hep?
- MENA Programme Region ranks 2nd and Palestine ranks 1st of 2 groups.
- Where does this data come from?
- UNICEF, published as Percentage of surviving infants who received the third dose of hep B-containing vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.